Hypoimmune CD19 CAR T cells evade allorejection in patients with cancer and autoimmune disease. Hu X, Beauchesne P, Wang C, Wong A, et al. Cell Stem Cell 2025 Aug 5:S1934-5909(25)00266.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Hu X, Beauchesne P, Wang C, Wong A, et al. Hypoimmune CD19 CAR T cells evade allorejection in patients with cancer and autoimmune disease. Cell Stem Cell 2025 Aug 5:S1934-5909(25)00266.
PMID: 40812299